From Financial Modeling Prep: 2025-05-28 20:00:00

Geron Corporation (NASDAQ:GERN) struggles with a ROIC of -26.79% below its WACC of 8.50%, indicating inefficiencies in generating returns. Stem, Inc. faces even greater challenges with a ROIC of -85.39% compared to a WACC of 4.80%. In contrast, Agenus Inc. shines with a ROIC of 1245.27% and a WACC of 76.38%, showing strong growth potential.



Read more at Financial Modeling Prep:: Geron Corporation’s Financial Analysis in the Biop…